{
  "id": "371e6540ec6baa03",
  "title": "Aspire Biopharma Files Provisional Patent Application for a Fast - Acting Sublingual Powder Formulation of Ondansetron ( Generic Zofran ( R )) ",
  "description": "20260212T164500Z",
  "content": "",
  "source": "californiatelegraph.com",
  "source_url": "http://www.californiatelegraph.com/news/278864118/aspire-biopharma-files-provisional-patent-application-for-a-fast-acting-sublingual-powder-formulation-of-ondansetron-generic-zofranr",
  "published_at": "20260212T164500Z",
  "fetched_at": "2026-02-13T00:31:20.432552+00:00",
  "category": "health_biotech",
  "subcategory": null,
  "keywords": [],
  "location": "United States",
  "raw_data": {
    "url": "http://www.californiatelegraph.com/news/278864118/aspire-biopharma-files-provisional-patent-application-for-a-fast-acting-sublingual-powder-formulation-of-ondansetron-generic-zofranr",
    "url_mobile": "",
    "title": "Aspire Biopharma Files Provisional Patent Application for a Fast - Acting Sublingual Powder Formulation of Ondansetron ( Generic Zofran ( R )) ",
    "seendate": "20260212T164500Z",
    "socialimage": "",
    "domain": "californiatelegraph.com",
    "language": "English",
    "sourcecountry": "United States"
  }
}